ZNF831 suppresses triple-negative breast cancer progression through NLRP3-associated pyroptotic signaling and M1-like macrophage phenotypic remodeling
Qingqing Liu, Jun Fan, Wantao Peng, Shuangwu Deng, Yupei Tan, Fei Guo, Jiangxue Zhong, Shimeng Zhou, Wenbin Liu, Yan Xu · 2026
Read ZNF831 suppresses triple-negative breast cancer progression through NLRP3-associated pyroptotic signaling and M1-like macrophage phenotypic remodeling by Qingqing Liu, Jun Fan, Wantao Peng, Shuangwu Deng, Yupei Tan, Fei Guo, Jiangxue Zhong, Shimeng Zhou, Wenbin Liu, Yan Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13390289.txt.
Description
Triple-negative breast cancer resists treatment partly by keeping the immune system quiet around it. Qingqing Liu and co-authors study a gene, ZNF831, that seems to break that silence. Across several patient data sets, tumors with more of the gene's activity fared better and showed a friendlier immune profile.
Raising the gene in cancer cells drew in macrophages and pushed them toward their attack-minded form. It also fired a fiery cell-death pathway that spills alarm signals. Blocking that pathway in mice weakened the effect. The gene seems to work by guarding a partner transcript and touching its promoter. The 2026 study casts ZNF831 as a brake on this cancer's spread.
Catalog record
| CREATOR | Qingqing Liu, Jun Fan, Wantao Peng, Shuangwu Deng, Yupei Tan, Fei Guo, Jiangxue Zhong, Shimeng Zhou, Wenbin Liu, Yan Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |